Go to the list of all blogs
Scott Bell's Avatar
published in Blogs
Nov 09, 2026
TickeronGET DAILY SIGNALS
IWM vs XSMO: Broad Small-Cap Exposure or a Momentum-Driven Approach?

IWM vs XSMO: Broad Small-Cap Exposure or a Momentum-Driven Approach?

Key Takeaways

  • IWM delivers broad, low-cost exposure to nearly 2,000 U.S. small-cap stocks, while XSMO holds a concentrated basket of roughly 115 momentum-selected small caps.
  • IWM charges a 0.19% expense ratio; XSMO's higher 0.35% fee reflects its rules-based momentum methodology and semi-annual rebalancing.
  • IWM is heavily weighted to Healthcare, Financials, Technology, and Industrials, whereas XSMO tilts toward Technology, Healthcare, Financial Services, and Real Estate.
  • XSMO's momentum tilt and higher turnover create greater relative concentration and turnover-driven risk, while IWM offers broader diversification and greater liquidity.
  • Tickeron AI Verdict: XSMO — Tickeron's AI favors XSMO for its trend consistency and relative momentum strength in the current small-cap environment.

Why Compare These Two Small-Cap ETFs?

Small-cap equities sit at the intersection of domestic economic momentum, interest-rate expectations, and sector rotation, making this a compelling moment for an ETF comparison. The iShares Russell 2000 ETF (IWM) and the Invesco S&P SmallCap Momentum ETF (XSMO) both provide U.S. small-cap exposure but pursue fundamentally different strategies. IWM is a broad, passive benchmark vehicle, while XSMO applies a momentum filter to a smaller universe. For investors weighing broad diversification against factor-driven return potential, understanding these structural differences is essential to assessing relative positioning and fund performance. I also checked this using Tickeron’s AI Screener to see how the two compare on technical and momentum metrics.

A Closer Look at IWM

The iShares Russell 2000 ETF (IWM) tracks the Russell 2000 Index, a float-adjusted, market-capitalization-weighted benchmark covering approximately 2,000 of the smallest companies in the Russell 3000. Issued by BlackRock and launched in May 2000, IWM is a passively managed fund that uses full replication and currently holds close to 2,000 securities.

Its expense ratio is 0.19%, among the lowest in the small-cap category, and its scale — tens of billions in assets under management (AUM) — makes it one of the most liquid small-cap vehicles available. Sector allocation skews toward Healthcare (roughly 20%), Financials (about 18%), Technology (around 14%), and Industrials (approximately 13%). Because the index is broad, no single holding dominates: top positions such as JFrog (FROG), Moog (MOG.A), UMB Financial (UMBF), and Glaukos (GKOS) each represent well under 0.5% of the fund, producing highly diversified, market-wide small-cap exposure.

Understanding XSMO’s Momentum Approach

The Invesco S&P SmallCap Momentum ETF (XSMO) tracks the S&P SmallCap 600 Momentum Index, selecting constituents of the S&P SmallCap 600 that exhibit the highest momentum scores — generally the strongest trailing price performance — and weighting them by a combination of market capitalization and momentum. Launched in March 2005 and issued by Invesco, the fund holds approximately 114 to 116 securities and rebalances semi-annually.

XSMO carries a 0.35% net expense ratio, higher than IWM's, reflecting its more concentrated, factor-driven construction and elevated portfolio turnover. Sector allocation leans toward Technology (roughly 17–23%), Healthcare (about 18–20%), Financial Services (approximately 14–16%), and Real Estate (around 12–13%). Concentration is materially higher: top holdings such as Viasat (VSAT), FormFactor (FORM), Victoria's Secret (VSCO), and Protagonist Therapeutics (PTGX) each represent several percent of assets, giving the fund a more targeted, growth-oriented small-cap profile.

The Current Small-Cap Environment

Both ETFs operate within the U.S. small-cap equity segment, a category highly sensitive to the domestic economic cycle, credit conditions, and Federal Reserve interest-rate policy. Recent market cycles have seen small caps respond to shifting rate expectations, as many smaller firms carry greater sensitivity to borrowing costs than large-cap peers. Sector rotation has favored areas such as financials, energy, and select technology names amid shifting growth expectations.

IWM's breadth captures this entire rotation broadly, while XSMO's momentum screen amplifies exposure to whatever segment is currently outperforming. Key catalysts include earnings dispersion across small-cap holdings, regional banking stability, reshoring and domestic manufacturing trends, and capital flows between growth and value styles. Risks for both funds include elevated volatility relative to large-cap benchmarks, economic slowdown sensitivity, and liquidity constraints in individual underlying names.

How They Stack Up in Performance and Risk

Across recent market cycles, XSMO's momentum methodology has tended to reward trend persistence within small caps, allowing it to outperform broader small-cap benchmarks during periods of sustained dispersion. IWM, by contrast, delivers market-wide small-cap beta with lower concentration and tracking error relative to the Russell 2000.

Relative positioning differs meaningfully. IWM's diversified exposure smooths idiosyncratic risk and closely mirrors the small-cap market. XSMO's concentration in higher-momentum names can enhance returns in trending markets but introduce sharper drawdowns during reversals. Volatility metrics show XSMO generally carrying a higher annualized volatility profile and greater turnover, while IWM benefits from superior liquidity and tighter bid-ask spreads. Cost is another differentiator, with IWM's 0.19% fee roughly half of XSMO's 0.35%.

Exploring with Tickeron’s AI Screener

When comparing these ETFs, I often turn to Tickeron’s AI Screener to filter for momentum characteristics, sector exposures, and technical signals. It helps me quickly identify how XSMO stacks up against broader options like IWM based on trends and volatility metrics, making the analysis more efficient.

Tickeron AI Verdict

Weighing structural strength, trend consistency, and relative momentum, Tickeron's AI would currently favor XSMO over IWM. The Invesco fund's momentum-driven selection process has aligned more closely with persistent small-cap leaders in recent market cycles, supporting stronger relative positioning. While IWM offers lower cost, broader diversification, and superior liquidity, XSMO's factor tilt has tended to capture trend continuation more effectively when small-cap dispersion is elevated. The verdict is probabilistic rather than prescriptive: XSMO's concentration and higher turnover imply greater risk, and outcomes remain contingent on whether prevailing momentum trends persist.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: IWM, XSMO

Contributor

Scott Bell's AvatarScott Bell|Expert

I’m a trader and independent researcher. My interest lies at the intersection of financial markets, algorithms, and capital management. I develop data-driven tools and strategies and study algorithmic approaches to market analysis. I help turn complex market data into clear insights and practical systems. I believe technology should support, not replace, investment thinking


Momentum Indicator for IWM turns negative, indicating new downward trend

IWM saw its Momentum Indicator move below the 0 level on November 05, 2026. This is an indication that the stock could be shifting in to a new downward move. Traders may want to consider selling the stock or exploring put options. Tickeron's A.I.dvisor looked at 95 similar instances where the indicator turned negative. In 84 of the 95 cases, the stock moved further down in the following days. The odds of a decline are at 88%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 48 of 59 cases where IWM's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 81%.

IWM moved below its 50-day moving average on November 05, 2026 date and that indicates a change from an upward trend to a downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where IWM declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 83%.

IWM broke above its upper Bollinger Band on October 29, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for IWM entered a downward trend on October 27, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where IWM's RSI Oscillator exited the oversold zone, 19 of 25 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 76%.

The Moving Average Convergence Divergence (MACD) for IWM just turned positive on October 21, 2026. Looking at past instances where IWM's MACD turned positive, the stock continued to rise in 36 of 43 cases over the following month. The odds of a continued upward trend are 84%.

Following a +1.75% 3-day Advance, the price is estimated to grow further. Considering data from situations where IWM advanced for three days, in 269 of 318 cases, the price rose further within the following month. The odds of a continued upward trend are 85%.

Notable companies

The most notable companies in this group are Abercrombie & Fitch Co (NYSE:ANF), Transocean Ltd (NYSE:RIG), Valaris Limited (NYSE:VAL), Synaptics (NASDAQ:SYNA), Signet Jewelers Limited (NYSE:SIG), Adaptive Biotechnologies Corp (NASDAQ:ADPT), Tanger (NYSE:SKT), California Resources Corp (NYSE:CRC), Lumen Technologies (NASDAQ:LUMN), Scorpio Tankers (NYSE:STNG).

Industry description

The investment seeks to track the investment results of the Russell 2000® Index, which measures the performance of the small-capitalization sector of the U.S. equity market. The underlying index is a float-adjusted capitalization-weighted index of equity securities issued by the approximately 1,933 smallest issuers in the Russell 3000 Index. The fund may use derivatives to gain or reduce exposure to the components of the underlying index or exposure to one or more market risk factors associated with such components.

Market Cap

The average market capitalization across the iShares Russell 2000 ETF (IWM) ETF is 2.12B. The market cap for tickers in the group ranges from 11.94M to 13.29B. BTSG holds the highest valuation in this group at 13.29B. The lowest valued company is INV at 11.94M.

High and low price notable news

The average weekly price growth across all stocks in the iShares Russell 2000 ETF (IWM) ETF was 2,393%. For the same ETF, the average monthly price growth was 1,506%, and the average quarterly price growth was 6,505%. ARRY experienced the highest price growth at 73%, while AIRS experienced the biggest fall at -69%.

Volume

The average weekly volume growth across all stocks in the iShares Russell 2000 ETF (IWM) ETF was 12%. For the same stocks of the ETF, the average monthly volume growth was 23% and the average quarterly volume growth was -27%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 52
P/E Growth Rating: 50
Price Growth Rating: 56
SMR Rating: 71
Profit Risk Rating: 78
Seasonality Score: 10 (-100 ... +100)
View a ticker or compare two or three
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

Category SmallBlend

Category
Small Blend
Address
iShares Trust400 Howard StreetSan Francisco
Phone
415-670-2000
Web
www.ishares.com
Interact to see
Advertisement
The Bitwise Solana Staking ETF (BSOL) advanced roughly 18% over the trailing 30 days, closely tracking a sharp rally in Solana (SOL). The move extends a broader recovery, with BSOL up approximately 77% over the past three months from its mid-2026 trough.
MSTY is an actively managed single-stock option income ETF (exchange-traded fund) that writes call options on Strategy (MSTR), formerly MicroStrategy, to generate current income. The portfolio is anchored by U.S. Treasury bills and MSTR option contracts rather than a diversified basket of equities, concentrating exposure in one volatile underlying.
AMDL has surged roughly +64% over the past 30 days, from about $47.59 to $78.10, mirroring a powerful rally in its sole underlying stock, AMD . The fund is a leveraged single-stock ETF (exchange-traded fund) designed to deliver 2x the daily return of AMD, amplifying both gains and losses.
LRCX stock surged +24% over the last 30 days, driven primarily by a strong Q3 fiscal 2026 earnings beat with revenue up 24% year-over-year to $5.84 billion and adjusted EPS of $1.47, exceeding estimates. Over the past quarter, the stock rose +22%, reflecting sustained AI-driven demand for semiconductor manufacturing equipment amid robust wafer fabrication equipment (WFE) spending forecasts.
ABT stock declined approximately -14% over the past 30 days, driven primarily by a post-earnings sell-off following Q1 results and lowered full-year profit guidance due to the Exact Sciences acquisition. Over the past quarter, the stock fell around -20%, reflecting broader pressures from weaker nutrition and diagnostics segments amid a challenging respiratory season.